The patient was at a facility in Minneola, Florida, while the surgeon operated remotely from another facility ...

The multicenter StereoBed trial will randomize 284 patients to compare five-fraction stereotactic radiotherapy with standard ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...

A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...

The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

A doctor in Florida performed a medical first on Sunday, using a robotic telesurgery system to perform a surgery at a ...

There will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including chemotherapy, hormone therapy, ablative therapy ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Israeli Prime Minister Benjamin Netanyahu, 75, had his prostate removed ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...